| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.4M | — | -0.2% |
| Cost of Revenue | $4.8M | — | -35.1% |
| Gross Profit | $4.6M | — | +123.1% |
| R&D Expense | $2K | — | -75.9% |
| SG&A Expense | $602K | — | -24.6% |
| Operating Income | $1.3M | — | +167.3% |
| Interest Expense | $89K | — | — |
| Pre-tax Income | $548K | — | -44.4% |
| Income Tax | $975K | — | +35.1% |
| Net Income | -$426K | — | -260.4% |
| EPS (Basic) | -$0.00 | — | -200.0% |
| EPS (Diluted) | -$0.00 | — | -300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.8M | +162.7% | — |
| Accounts Receivable | $2.6M | +65.4% | — |
| Inventory | $3.6M | +7.0% | — |
| Current Assets | $13.7M | +68.6% | — |
| Total Assets | $41.9M | +15.0% | — |
| Current Liabilities | $7.9M | -6.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $395K | — | +121.5% |
| Capital Expenditures | $495K | — | +205.3% |
| Investing Cash Flow | -$495K | — | -205.3% |
| Financing Cash Flow | $3.7M | — | +1914.9% |
| Free Cash Flow | -$100K | — | +95.0% |
| Total Liabilities | $47.6M | +6.6% | — |
| Stockholders' Equity | -$5.7M | +30.5% | +46.0% |